Please use this identifier to cite or link to this item:
|Title:||Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype||Authors:||Sabapathy, Tr.K.
|Issue Date:||1995||Citation:||Sabapathy, Tr.K., Cheng, Q., Hui, K.M. (1995). Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype. Cellular Immunology 166 (1) : 141-153. ScholarBank@NUS Repository. https://doi.org/10.1006/cimm.1995.0016||Abstract:||The introduction and expression of allogeneic MHC class I genes in tumors can generate tumor-specific immunity which subsequently results in the regression of parental tumors. Immunization of naive (AKR/J x C57BL/6)F1 mice with H-2K(b)-transformed K36 tumor cells was found to render recipient mice immune to a subsequent challenge by parental K36 tumor cells. Two types of cytotoxic T effector cells were demonstrated in these immune mice. One of the cytotoxic effector cells generated against the K36 tumor cells is the conventional CD3+ cells, and these account for approximately one-third of the total observed tumor-specific cytotoxicity in vitro. The other cytotoxic effector cell generated following the immunization of (AKR/J x C57BL/6)F1 mice with the H-2K(b)-transformed K36 cells had the CD3-/Thy-1+ phenotype, and accounted for the remaining two-thirds of the observed tumor-specific cytotoxicity in vitro. These CD3-/Thy-1+ cells can lyse parental K36 tumor cells in a tumor-specific fashion, and tumor-specific immunity can be adoptively transferred to naive animals via the CD3-/Thy-1+ cells. In contrast to CD3+ CTL, CD3-/Thy-1+ cells express CD45RB(low) Ly-6C(high), and HSA molecules. Although the CD3-/Thy-1+ cells can be activated in vitro by IL-2, TPA, and ionomycin, they cannot be propagated in vitro. The CD3-/Thy-1+ cells undergo apoptosis following prolonged culture in vitro. At present, the exact mechanism(s) by which CD3-/Thy-1+ cells can mediate tumor-specific cell lysis in the absence of identifiable T cell receptor molecules is unknown; nevertheless, these data suggest the existence of a novel T cell type to combat tumors.||Source Title:||Cellular Immunology||URI:||http://scholarbank.nus.edu.sg/handle/10635/111821||ISSN:||00088749||DOI:||10.1006/cimm.1995.0016|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Aug 15, 2022
WEB OF SCIENCETM
checked on Aug 15, 2022
checked on Aug 18, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.